Aprea Therapeutics Inc (APRE)

Currency in USD
1.675
+0.015(+0.90%)
Real-time Data·
APRE Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
APRE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.6201.720
52 wk Range
1.4125.010
Key Statistics
Prev. Close
1.65
Open
1.62
Day's Range
1.62-1.72
52 wk Range
1.412-5.01
Volume
37.26K
Average Volume (3m)
51.35K
1-Year Change
-50.75%
Book Value / Share
2.83
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
APRE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
10.500
Upside
+526.87%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Aprea Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

Aprea Therapeutics Inc Company Profile

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidates are APR-1051, an orally bioavailable small-molecule inhibitor of WEE1 kinase that is in Phase 1 clinical trial for the treatment of patients with advanced solid tumors with biomarkers; and ATRN-119, an ATR inhibitor, which is in Phase 1/2a clinical trial for solid tumor indications. The company is headquartered in Doylestown, Pennsylvania.

Compare APRE to Peers and Sector

Metrics to compare
APRE
Peers
Sector
Relationship
P/E Ratio
−0.7x−0.5x−0.5x
PEG Ratio
−0.02−0.060.00
Price/Book
0.6x1.7x2.6x
Price / LTM Sales
7.3x8.7x3.3x
Upside (Analyst Target)
-303.3%43.4%
Fair Value Upside
Unlock8.5%7.1%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 10.500
(+526.87% Upside)

Earnings

Latest Release
May 14, 2025
EPS / Forecast
-0.66 / -1.00
Revenue / Forecast
162.46K / --
EPS Revisions
Last 90 days

APRE Income Statement

People Also Watch

0.375
ADIL
-3.23%
18.51
SRPT
+3.06%
250.54
AVAV
-3.49%
3.48
ALT
-1.28%
9.1700
CYCC
+2.23%

FAQ

What Stock Exchange Does Aprea Thera Trade On?

Aprea Thera is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Aprea Thera?

The stock symbol for Aprea Thera is "APRE."

What Is the Aprea Thera Market Cap?

As of today, Aprea Thera market cap is 9.40M.

What Is Aprea Thera's Earnings Per Share (TTM)?

The Aprea Thera EPS (TTM) is -2.36.

From a Technical Analysis Perspective, Is APRE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Aprea Thera Stock Split?

Aprea Thera has split 0 times.

How Many Employees Does Aprea Thera Have?

Aprea Thera has 8 employees.

What is the current trading status of Aprea Thera (APRE)?

As of 08 Aug 2025, Aprea Thera (APRE) is trading at a price of 1.68, with a previous close of 1.65. The stock has fluctuated within a day range of 1.62 to 1.72, while its 52-week range spans from 1.41 to 5.01.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.